Get notified of page updates

All XRAYs

FORCE's eXamining the Relevance of Articles for You (XRAY) program looks behind the headlines of cancer news to help you understand what the research means for you. XRAY is a reliable source of hereditary cancer research-related news and information.
Showing 181 through 190 out of 343

Relevance: Medium-Low

Most relevant for: Women diagnosed with Ductal Carcinoma In Situ (DCIS)

Personal Story: A “flu shot” against breast cancer? Not so fast

There have been multiple reports in the media of a Florida woman who had a "shot" to treat her DCIS with a promising outcome. This XRAY reviews the underlying story about this early breast cancer vaccine trial. (10/25/19)

READ MORE  ›

Relevance: High

Most relevant for: Women with metastatic breast cancer

Personal Story: Running marathons with metastatic breast cancer? Yes!

Runner’s World Magazine featured Sarah Smith, a metastatic breast cancer patient who runs marathons and ultra-marathons. By telling her story, Sarah wants to encourage people to stay active, despite the challenges that life may bring. (10/13/19)

READ MORE  ›

Relevance: Medium-High

Most relevant for: People with early stage breast cancer who have an inherited BRCA mutation

Study: Research on the PARP inhibitor talazoparib (Talzenna) for early-stage breast cancer is promising

The PARP inhibitor talazoparib (Talzenna) has been useful for treatment of advanced or metastatic breast cancer for patients with BRCA mutations. A preliminary study showed that the majority of patients who took talazoparib alone before surgery for early-stage breast cancer had effective treatment and manageable side effects. Expanded clinical trials are in progress to verify this result. (10/4/19)

READ MORE  ›

Relevance: Medium-High

Most relevant for: People with metastatic breast cancer

Study: Inherited mutations in metastatic breast cancer patients

Recent research shows that a significant portion of patients with metastatic breast cancer have harmful mutations in a gene associated with hereditary breast cancer and increased breast cancer risk. (9/26/19)

READ MORE  ›

Relevance: Medium-High

Most relevant for: People currently taking a CDK inhibitor

Guideline: FDA issues warning on CDK inhibitors

The U.S. Food and Drug Administration issued a safety alert for CDK inhibitors, including Ibrance (palbociclib), Kisqali (ribociclib), and Verzenio (abemaciclib). (9/24/19)

READ MORE  ›

Relevance: Medium-High

Most relevant for: Women with a family history of breast cancer

Study: Does eating meat affect breast cancer risk?

Eating meat has been suggested to increase breast cancer risk. The recent Sister Study looked at meat type, cooking methods and breast cancer risk in a study of 42,012 women.  (9/10/19)

READ MORE  ›

Relevance: High

Most relevant for: Women with a BRCA mutation who are considering pregnancy after breast cancer

Study: Is it safe for BRCA mutation carriers to become pregnant following breast cancer?

New research shows that pregnancy after breast cancer is safe for women with BRCA mutations and their babies. (9/4/19)

READ MORE  ›

Relevance: High

Most relevant for: People diagnosed with metastatic breast cancer

Study: Supportive care can improve quality of life for people with metastatic breast cancer

Metastatic breast cancer patients have unique needs for treatment and care. Connecting patients to appropriate support services and palliative care is an area of need in health care. A recent study reported improvement in metastatic breast cancer patient quality of life and wellness with an intervention program called the Supportive, Education and Advocacy (MBC-SEA) program. (8/21/19)

READ MORE  ›

Relevance: High

Most relevant for: People with a personal or family history of cancer where no mutation has been found

Study: MRI or mammograms for detecting breast cancer in families with unknown genetic mutations?

MRI and mammograms are used together to detect breast cancer in high-risk women who test positive for a BRCA or other gene mutation that increases the risk for breast cancer. For women with a family history of breast cancer but no known genetic mutation, increased screening is recommended. But what method is best? A recent clinical trial in the Netherlands compared MRI and mammography for this population. (8/15/19)

READ MORE  ›

Relevance: Medium-High

Most relevant for: Young women who find a breast lump and young women newly-diagnosed with breast cancer

Study: Diagnosis and treatment delays in young women with breast cancer

Young women are more likely to have delays in a breast cancer diagnosis and treatment.  Factors that affect these delays include pregnancy, breastfeeding, financial concerns and having a family history of breast or ovarian cancer. (8/5/19)

Este artículo está disponible en español.

READ MORE  ›